TEHMINA NAVEED: Open Payments
NPI 1891873691 · PLAINVIEW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,342 in 31 payments from 9 companies in 2025. Trend: 2023 $1,217 · 2024 $1,253 · 2025 $1,342
Food & beverage: $1,342
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $313 |
| Lilly USA, LLC | 9 | $269 |
| AstraZeneca Pharmaceuticals LP | 8 | $260 |
| Novo Nordisk Inc | 2 | $148 |
| Braeburn Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Exact Sciences Corporation | 2 | $45 |
| Amgen Inc. | 2 | $37 |
| PFIZER INC. | 1 | $20 |
Products named: JARDIANCE, FARXIGA, Ozempic, BRIXADI, Auvelity, ZEPBOUND, Cologuard Collection Kit, MOUNJARO.
Industry payments across NY — which companies pay providers there.
